CRON logo

Cronos (CRON)

Profile

Full Name

Cronos Group Inc.

Ticker Symbol

CRON

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

Canada

IPO

February 27, 2018

Indexes

Not included

Website

http://www.thecronosgroup.com

Employees

459

Key Details

Price

$1.80

Market Cap

$688.52M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$117.61M(+34.82% YoY)

Annual EPS

$0.11(+157.89% YoY)

PE Ratio

16.36

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.80
CRON price is $1.80

Price All-time High

$23.70
CRON price is currently -92.41% below its historical high of $23.70

Price Most Recent Change

-2.16%
CRON price was down -2.16% on Mar 28, 2025

Price YTD Change

-10.45%
CRON price is down -10.45% since January 1st

Price 1-year Change

-31.04%
CRON price is down -31.04% year-on-year

Price 3-year Change

-54.43%
CRON price is down -54.43% over the past 3 years

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market Cap

$688.52M
CRON market capitalization is $688.52 million

Market Cap 3-year Change

-53.51%
CRON market capitalization is down -53.51% over the past 3 years

Market Cap All-time High

$7.14B
CRON market capitalization is currently -90.36% below its historical high of $7.14 billion

Market Cap Sector Rank

72.07%
CRON market capitalization is higher than 72.07% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.32%
CRON shares outstanding is up +0.32% year-on-year

Shares Outstanding 3-Year Change

+2.02%
CRON shares outstanding is up +2.02% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.81
CRON beta is 0.81

200-day SMA

$2.12
CRON price is currently -15.24% below its 200-day simple moving average

50-day SMA

$1.92
CRON price is currently -6.37% below its 50-day simple moving average

RSI

40.11
CRON 14-day relative strength index is 40.11

Volume

0.60
CRON 30-day relative volume is 0.60

ATR

$0.07
CRON average true range is $0.07

10-day Historical Volatility

38.35%
CRON 10-day historical volatility is 38.35%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$117.61M
CRON annual revenue is $117.61 million

Revenue Analysts Estimate

$208.66M
CRON annual revenue is currently -43.63% lower than the consensus analysts' forecast

Revenue 1-year Change

+34.82%
CRON annual revenue is up +34.82% year-on-year

Revenue Sector Rank

57.92%
CRON annual revenue is higher than 57.92% of companies in Healthcare sector

EPS

EPS

$0.11
CRON annual earnings per share is $0.11

EPS Analysts Estimate

-
CRON annual earnings per share consensus analysts' forecast is unknown

EPS 1-year Change

+157.89%
CRON annual earnings per share is up +157.89% year-on-year

EPS Sector Rank

84.07%
CRON annual earnings per share is higher than 84.07% of companies in Healthcare sector

Profit

Gross Profit

$25.20M
CRON annual gross profit is $25.20 million

Gross Margin

21.42%
CRON annual gross profit margin is 21.42%

Operating Profit

-$59.55M
CRON annual operating income is -$59.55 million

Operating Margin

-50.63%
CRON annual operating profit margin is -50.63%

Net Income

$41.08M
CRON annual net profit is $41.08 million

Net Margin

34.93%
CRON annual net profit margin is 34.93%

Expenses

Total Expenses

$177.16M
CRON annual total expenses is $177.16 million

Operating Expenses

$84.75M
CRON annual total operating expenses is $84.75 million

Cost Of Goods Sold

$92.42M
CRON annual cost of goods sold is $92.42 million

Selling, General & Administrative Expenses

$76.82M
CRON annual SGA is $76.82 million

Depreciation And Amortization

$9.34M
CRON annual depreciation & amortization is $9.34 million

Interest Expense

-
CRON annual interest expense value is unknown

Income Tax

-$3.44M
CRON annual income tax is -$3.44 million

EBIT & EBITDA

EBIT

-$59.55M
CRON annual earnings before interest & taxes is -$59.55 million

EBITDA

-$50.21M
CRON annual EBITDA is -$50.21 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total Assets

$1.17B
CRON annual total assets is $1.17 billion

Non Current Assets

$230.07M
CRON annual long term assets is $230.07 million

Current Assets

$936.11M
CRON annual total current assets is $936.11 million

Cash And Cash Equivalents

$858.80M
CRON annual cash & cash equivalents is $858.80 million

Accounts Receivable

$15.46M
CRON annual accounts receivable is $15.46 million

Inventory

$33.15M
CRON annual inventory is $33.15 million

Liabilities

Total Liabilities

$55.33M
CRON annual total liabilities is $55.33 million

Long Term Liabilities

$5.63M
CRON annual total long term liabilities is $5.63 million

Current Liabilities

$49.70M
CRON annual total current liabilities is $49.70 million

Accounts Payable

$16.97M
CRON annual accounts payable is $16.97 million

Debt

Total Debt

$2.02M
CRON annual total debt is $2.02 million

Total Debt 1-year Change

-20.96%
CRON annual total debt is down -20.96% year-on-year

Long Term Debt

$993.00K
CRON annual long term debt is $993.00 thousand

Short Term Debt

$1.02M
CRON annual short term debt is $1.02 million

Equity & Capital

Shareholders Equity

$1.06B
CRON annual stockholders equity is $1.06 billion

Book Value

$1.06B
CRON annual book value is $1.06 billion

Retained Earnings

$457.71M
CRON annual retained earnings is $457.71 million

Working Capital

$886.41M
CRON annual working capital is $886.41 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash From Operations

$18.84M
CRON annual cash flow from operations is $18.84 million

Cash From Operations 1-year Change

+143.99%
CRON annual cash flow from operations is up +143.99% year-on-year

Cash From Investing

$175.15M
CRON annual cash flow from investing activities is $175.15 million

Cash From Investing 1-year Change

+394.37%
CRON annual cash flow from investing activities is up +394.37% year-on-year

Cash From Financing

-$1.23M
CRON annual cash flow from financing activities is -$1.23 million

Cash From Financing 1-year Change

-19.51%
CRON annual cash flow from financing activities is down -19.51% year-on-year

CAPEX

CAPEX

$13.15M
CRON annual capital expenditures is $13.15 million

CAPEX 1-year Change

+284.28%
CRON annual capital expenditures is up +284.28% year-on-year

Free Cash Flow

Free Cash Flow

$5.69M
CRON annual free cash flow is $5.69 million

Free Cash Flow 1-year Change

+112.3%
CRON annual free cash flow is up +112.3% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross Margin

21.42%
CRON annual gross profit margin is 21.42%

Operating Margin

-50.63%
CRON annual operating profit margin is -50.63%

Net Margin

34.93%
CRON annual net profit margin is 34.93%

ROA & ROE

ROA

3.56%
CRON annual return on assets is 3.56%

ROE

3.72%
CRON annual return on equity is 3.72%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

16.36
CRON price to earnings ratio is 16.36

PE Ratio Sector Rank

26.21%
CRON price to earnings ratio is higher than 26.21% of companies in Healthcare sector

PB Ratio

PB Ratio

0.65
CRON price to book ratio is 0.65

PB Ratio Sector Rank

32.84%
CRON price to book ratio is higher than 32.84% of companies in Healthcare sector

PS Ratio

PS Ratio

5.85
CRON price to sales ratio is 5.85

PS Ratio Sector Rank

67.92%
CRON price to sales ratio is higher than 67.92% of companies in Healthcare sector

Enterprise value

Enterprise Value

-$168.27M
CRON enterprise value is -$168.27 million

Enterprise Value Sector Rank

0.25%
CRON enterprise value is higher than 0.25% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

3.35
CRON EV/EBITDA is 3.35

EV/EBITDA Sector Rank

76.92%
CRON EV/EBITDA is higher than 76.92% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current Ratio

18.84
CRON annual current ratio is 18.84

Quick Ratio

18.17
CRON annual quick ratio is 18.17

Leverage

Debt To Equity

0.00
CRON annual debt to equity ratio is 0.00

Interest Coverage Ratio

-
CRON annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

6
CRON piotroski f-score is 6

Altman Z-Score

8.86
CRON altman z-score is 8.86

Analyst ratings

Recent major analysts updates

May 15, 24 CIBC
Outperformer
Apr 8, 24 B of A Securities
Underperform
Dec 28, 23 B of A Securities
Underperform
May 15, 23 Barclays
Equal-Weight
Nov 2, 22 Bernstein
Market Perform
Sep 30, 22 Barclays
Equal-Weight
Mar 22, 22 Barclays
Equal-Weight
Mar 7, 22 Piper Sandler
Neutral
Feb 22, 22 Piper Sandler
Neutral
Feb 22, 22 Canaccord Genuity
Sell

Institutional Ownership

Similar stocks

GHRS logo
GH Research (GHRS)
ABCL logo
AbCellera Biologics (ABCL)
CVAC logo
CureVac NV (CVAC)
QURE logo
uniQure NV (QURE)
PRTA logo
Prothena (PRTA)
LENZ logo
LENZ Therapeutics (LENZ)
IRMD logo
IRadimed (IRMD)
ABUS logo
Arbutus Biopharma (ABUS)
EMBC logo
Embecta (EMBC)
  • What is the ticker symbol for Cronos?
  • Does Cronos pay dividends?
  • What sector is Cronos in?
  • What industry is Cronos in?
  • What country is Cronos based in?
  • When did Cronos go public?
  • Is Cronos in the S&P 500?
  • Is Cronos in the NASDAQ 100?
  • Is Cronos in the Dow Jones?
  • When was Cronos's last earnings report?
  • When does Cronos report earnings?
  • Should I buy Cronos stock now?

What is the ticker symbol for Cronos?

The ticker symbol for Cronos is NASDAQ:CRON

Does Cronos pay dividends?

No, Cronos does not pay dividends

What sector is Cronos in?

Cronos is in the Healthcare sector

What industry is Cronos in?

Cronos is in the Drug Manufacturers - Specialty & Generic industry

What country is Cronos based in?

Cronos is headquartered in Canada

When did Cronos go public?

Cronos's initial public offering (IPO) was on February 27, 2018

Is Cronos in the S&P 500?

No, Cronos is not included in the S&P 500 index

Is Cronos in the NASDAQ 100?

No, Cronos is not included in the NASDAQ 100 index

Is Cronos in the Dow Jones?

No, Cronos is not included in the Dow Jones index

When was Cronos's last earnings report?

Cronos's most recent earnings report was on Feb 27, 2025

When does Cronos report earnings?

The next expected earnings date for Cronos is May 9, 2025

Should I buy Cronos stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page